Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Piqray 200mg+50mg


Contraindicated
Foetotoxicity

Contraindicated
Piqray 200mg+50mg :
Type Medicine Authorised
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Novartis Pharma Stein AG
Origin Switzerland
ATC L01XX65

Your comment will appear shortly after approval

Piqray 200mg+50mg :

Revision Date : 01/05/2019


Effect Frequency
Abdominal pain Very Common
Activated partial thromboplastin time prolonged Very Common
Albumin low Very Common
Alopecia Very Common
ALT increased Very Common
Creatinine increased Very Common
Decreased appetite Very Common
Diarrhoea (Diarrhea) Very Common
Dry skin Very Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Very Common
Fatigue Very Common
Gamma-GT increased Very Common
Glucose decreased Very Common
Glucose increased Very Common
Haemoglobin decreased Very Common
Headache Very Common
Hypercalcaemia Very Common
Hypokalaemia Very Common
Hypomagnesaemia Very Common
Lipase increased Very Common
Lymphocyte count decreased Very Common
Mucosal dryness Very Common
Mucosal inflammation Very Common
Nausea Very Common
Oedema peripheral Very Common
Platelet count decreased (Thrombocyte count decreased) Very Common
Pruritus Very Common
Pyrexia Very Common
Skin rash Very Common
Stomatitis Very Common
Urinary tract infection Very Common
Vomiting Very Common
Weight decreased (Weight loss) Very Common

Different Units By MoH Code

Revision Date : 01/05/2019

Revision Date : 01/05/2019

Piqray 200mg+50mg  MoH 11003 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 28+28
Strength 200mg/50mg
Storage Condition <30°C protect from humidity & light
Public Price 5891688 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 32721/1
Submission date 2021
Registration Year 01/02/2023


NB : Reregistration in 2023 with same manufacturer

Price Comparison

● Country: Oman
● Package Size: 28 OF 50MG + 28 OF 200MG (56)
● Public Price: 3182.03 OMR ( 734,202,510.02 LBP )
● Pack size unit used: 56
● Cost/Unit: 56,822 OMR ( 12,921,104.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 56
● Public Price: 4514.35 CHF ( 466,874,077.00 LBP )
● Pack size unit used: 56
● Cost/Unit: 80,6134 CHF ( 8,273,600.00 LBP )
● Exfactory Price: 4164.24 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 56
● Public Price: 4082.14 GBP ( 463,931,128.86 LBP )
● Pack size unit used: 56
● Cost/Unit: 72,8954 GBP ( 8,182,728.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 28 + 28 stk
● Public Price: 34121.9 DKK ( 442,765,774.40 LBP )
● Pack size unit used: 56
● Cost/Unit: 609,3196 DKK ( 7,902,384.00 LBP )
● Pharmacy Price: 25364.35 DKK ( 329127805.6 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: KSA
● Package Size: 56
● Public Price: 17606.34 SAR ( 416,213,877.60 LBP )
● Pack size unit used: 56
● Cost/Unit: 314,3989 SAR ( 7,422,960.00 LBP )
● Reference: sfda
● Pricing Date: 16/01/2021
● Type: Medicine Authorised

● Country: Finland
● Package Size: 56
● Public Price: 4037.13 EUR ( 391,101,005.88 LBP )
● Pack size unit used: 56
● Cost/Unit: 72,0916 EUR ( 6,975,072.00 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 56
● Public Price: 3927.92 EUR ( 380,521,177.92 LBP )
● Pack size unit used: 56
● Cost/Unit: 70,1414 EUR ( 6,781,320.00 LBP )
● Pharmacy Price: 3930.92 EUR ( 380811805.92 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 23/03/2021
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 28's (14 tabs of 200mg and 14 tabs of 50mg)
● Public Price: 15111 QAR ( 371,095,938.00 LBP )
● Pack size unit used: 56
● Cost/Unit: 269,8393 QAR ( 6,606,102.00 LBP )
● Pharmacy Price: 12412.4169 QAR ( 304824134.2302 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 56
● Public Price: 14120 AED ( 341,153,320.00 LBP )
● Pack size unit used: 56
● Cost/Unit: 252,1429 AED ( 6,088,572.00 LBP )
● Pharmacy Price: 12028.4 AED ( 290618172.4 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Greece
● Package Size: 56
● Public Price: 3515.46 EUR ( 340,563,702.96 LBP )
● Pack size unit used: 56
● Cost/Unit: 62,7761 EUR ( 6,006,312.00 LBP )
● Exfactory Price: 3203.385 EUR
● Pharmacy Price: 3251.44 EUR ( 314986501.44 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021

● Country: Lebanon
● Form: Tablet, Film-Coated
● Package Size: Box of 28+28
● Public Price: 5891688 LBP ( 5,891,688.00 LBP )
● Pack size unit used: 56
● Cost/Unit: 105208,71 LBP ( 105,208.00 LBP )
● Pricing Date: 13/06/2024

● Country: France
● Package Size: 56
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 56,822 OMR ( 12,921,104.00 LBP )
● Cost/Day: 113,64 OMR ( 26,072,942.00 LBP )
● Cost/Month: 3409,2 OMR ( 786,572,206.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 56,822 OMR ( 12,921,104.00 LBP )
● Cost/Day: 113,64 OMR ( 26,072,942.00 LBP )
● Cost/Month: 3409,2 OMR ( 786,572,206.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 80,6134 CHF ( 8,273,600.00 LBP )
● Cost/Day: 161,23 CHF ( 16,650,620.00 LBP )
● Cost/Month: 4836,9 CHF ( 500,139,120.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 80,6134 CHF ( 8,273,600.00 LBP )
● Cost/Day: 161,23 CHF ( 16,650,620.00 LBP )
● Cost/Month: 4836,9 CHF ( 500,139,120.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 72,8954 GBP ( 8,182,728.00 LBP )
● Cost/Day: 145,79 GBP ( 16,479,105.00 LBP )
● Cost/Month: 4373,7 GBP ( 496,987,077.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 72,8954 GBP ( 8,182,728.00 LBP )
● Cost/Day: 145,79 GBP ( 16,479,105.00 LBP )
● Cost/Month: 4373,7 GBP ( 496,987,077.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 609,3196 DKK ( 7,902,384.00 LBP )
● Cost/Day: 1218,64 DKK ( 15,804,768.00 LBP )
● Cost/Month: 36559,2 DKK ( 474,389,584.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 609,3196 DKK ( 7,902,384.00 LBP )
● Cost/Day: 1218,64 DKK ( 15,804,768.00 LBP )
● Cost/Month: 36559,2 DKK ( 474,389,584.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 314,3989 SAR ( 7,422,960.00 LBP )
● Cost/Day: 628,8 SAR ( 14,845,920.00 LBP )
● Cost/Month: 18864 SAR ( 445,944,960.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 314,3989 SAR ( 7,422,960.00 LBP )
● Cost/Day: 628,8 SAR ( 14,845,920.00 LBP )
● Cost/Month: 18864 SAR ( 445,944,960.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 72,0916 EUR ( 6,975,072.00 LBP )
● Cost/Day: 144,18 EUR ( 13,950,144.00 LBP )
● Cost/Month: 4325,4 EUR ( 418,988,700.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 72,0916 EUR ( 6,975,072.00 LBP )
● Cost/Day: 144,18 EUR ( 13,950,144.00 LBP )
● Cost/Month: 4325,4 EUR ( 418,988,700.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 70,1414 EUR ( 6,781,320.00 LBP )
● Cost/Day: 140,28 EUR ( 13,562,640.00 LBP )
● Cost/Month: 4208,4 EUR ( 407,654,208.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 70,1414 EUR ( 6,781,320.00 LBP )
● Cost/Day: 140,28 EUR ( 13,562,640.00 LBP )
● Cost/Month: 4208,4 EUR ( 407,654,208.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 269,8393 QAR ( 6,606,102.00 LBP )
● Cost/Day: 539,68 QAR ( 13,236,762.00 LBP )
● Cost/Month: 16190,4 QAR ( 397,594,020.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 269,8393 QAR ( 6,606,102.00 LBP )
● Cost/Day: 539,68 QAR ( 13,236,762.00 LBP )
● Cost/Month: 16190,4 QAR ( 397,594,020.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 252,1429 AED ( 6,088,572.00 LBP )
● Cost/Day: 504,29 AED ( 12,177,144.00 LBP )
● Cost/Month: 15128,7 AED ( 365,507,608.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 252,1429 AED ( 6,088,572.00 LBP )
● Cost/Day: 504,29 AED ( 12,177,144.00 LBP )
● Cost/Month: 15128,7 AED ( 365,507,608.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 62,7761 EUR ( 6,006,312.00 LBP )
● Cost/Day: 125,55 EUR ( 12,109,500.00 LBP )
● Cost/Month: 3766,5 EUR ( 364,835,016.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 62,7761 EUR ( 6,006,312.00 LBP )
● Cost/Day: 125,55 EUR ( 12,109,500.00 LBP )
● Cost/Month: 3766,5 EUR ( 364,835,016.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 105208,71 LBP ( 105,208.00 LBP )
● Cost/Day: 210417,42 LBP ( 210,417.00 LBP )
● Cost/Month: 6312522,6 LBP ( 6,312,522.00 LBP )
Metastatic,postmenopausal breast cancer , hormone receptor-positive : (Adults)
● Cost/Unit: 105208,71 LBP ( 105,208.00 LBP )
● Cost/Day: 210417,42 LBP ( 210,417.00 LBP )
● Cost/Month: 6312522,6 LBP ( 6,312,522.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info